Becton false advertising and antitrust lawsuit heads to trial

August 22, 2013 by Arezu Sarvestani

A Texas judge permits Retractable Technologies Inc. to proceed with a lawsuit accusing rival Becton Dickinson of false advertising and violations of antitrust laws.

Becton must head to court to speak for antitrust and false advertising accusations

Becton Dickinson & Co. (NYSE:BDX) is headed to court next month to speak to allegations, brought by rival Retractable Technologies' (NYSE:RVP), that it engaged in illegal in order to maintain a monopoly in the syringe business.

A Texas federal judge dismissed Becton's motion for summary judgment, ruling that there is sufficient evidence "suggesting that [Becton’s] contracts have anticompetitive effects," Law360.com reported.

Sign up to get our free newsletters delivered right to your inbox.

The new trial is the latest in a long-running patent battle between the companies, which began in 2007 when Texas-based Retractable Technologies sued on allegations that Becton's Integra syringes infringe patents covering its competing VanishPoint devices.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp